The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Europe Healthcare CRO Market would witness market growth of 5.9% CAGR during the forecast period (2019-2025).
Healthcare project management helps companies improve and function more efficiently in several ways. Perhaps the greatest advantage of hospital project management is that it can minimize the possibility of litigation that prevails for every organization in healthcare. Step by step establishing processes removes as many adverse results as possible. Managing a project aligns money with the operation. In other words, it guarantees at various points of a project that you have the money for your efforts. You’ll know, for example, if you have the budget to start a project. As and when additional costs occur, it is important to have a mechanism in place to update the budget and re-prioritize as appropriate.
Growing investments by several governmental organizations in research & development activities and rising demand for successful therapies for chronic disease management are likely to raise the market sales of CRO services in North America over the forecast period. Due to increasing healthcare awareness, rising demand for technologically advanced and therapeutically successful products and huge spending on healthcare services in the region, the region is likely to continue its dominance.
Europe was found to be the second dominant region on the global contract research organization (CRO) services market in 2018 due to the strong emphasis on research and development activities of the region’s leading pharmaceutical, biotechnology and medtech firms.
Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.
Scope of the Study
Asia Pacific Healthcare CRO Market Segmentation
By Service Type
- Clinical Research Services
- Early Phase Development
- Laboratory Services and
- Consulting Services
By End User
- Pharmaceutical companies
- Medical Device Companies and
- Academic Institutes
By Therapeutic Area
- CNS Disorder
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Diseases and
- Other therapeutic areas
- Rest of Europe
- IQVIA Holdings, Inc.
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Pharmaceutical Product Development, Inc.
- Parexel International Corporation (Pamplona Capital Management)
- Charles River Laboratories International, Inc.
- ICON PLC
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Syneos Health, Inc.
- Pharmaron Beijing Co., Ltd.
- GVK Biosciences Private Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free